Tudor Investment Corp’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $745K | Sell |
|
|||||
|
2025
Q2 | $1.6M | Buy |
|
|||||
|
2025
Q1 | $788K | Buy |
|
|||||
|
2024
Q4 | $748K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $637K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.26M | Buy |
|
|||||
|
2023
Q3 | $669K | Buy |
|
|||||
|
2023
Q2 | $540K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.17M | Buy |
|
|||||
|
2022
Q2 | $255K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.88M | Buy |
|
|||||
|
2021
Q2 | $994K | Buy |
|
|||||
|
2021
Q1 | $589K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $98K | Sell |
|
|||||
|
2019
Q4 | $528K | Buy |
|
|||||
|
2019
Q3 | $169K | Buy |
|
|||||
|
2019
Q2 | $140K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $537K | Buy |
|
|||||
|
2017
Q2 | $233K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $49K | Sell |
|
|||||
|
2016
Q2 | $47K | Sell |
|
|||||
|
2016
Q1 | $355K | Buy |
|
|||||
|
2015
Q4 | $115K | Sell |
|
|||||
|
2015
Q3 | $337K | Buy |
|
|||||
|
2015
Q2 | $199K | Buy |
|